Lichen Planus

• CLINICAL_TRIALS research · 2014-10-10
  Clinical Trial Update: Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV Infection [NA]

  This clinical trial update discusses the use of ribavirin off-label for mucocutaneous extrahepatic manifestations of hepatitis C, such as li…

• CLINICAL_TRIALS trial_result · 2014-08-29
  Clinical Trial Update: Exploratory Study of Natural Killer Cells in Human Skin [NA]

  Clinical trial update indicates completion of an exploratory study of natural killer cells in human skin, covering Atopic dermatitis, Contac…

• FDA label_change · 2012-09-07
  FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)

  FDA approved a supplemental application for CLOBEX (clobetasol propionate) from Galderma Laboratories, L.P. The approval updates the product…

• FDA approval · 2012-08-17
  FDA Approved: CLOBEX — Supplemental Application (Galderma Laboratories, L.P.)

  The FDA approved a supplemental application for CLOBEX (clobetasol propionate) submitted by Galderma Laboratories to update its labeling.

• CLINICAL_TRIALS trial_result · 2012-03-20
  Clinical Trial Update: Lichen Planus Mucosae at USZ, Efficacy of Oral Alitretinoin [Phase 2]

  Phase 2 clinical trial at the University of Zurich evaluating the efficacy of oral alitretinoin in lichen planus mucosae.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2010-01-01
  Clinical Trial Update: Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus [Phase 2]

  A Phase 2 pilot study is evaluating apremilast for moderate to severe lichen planus, with the trial status not disclosed.

• CLINICAL_TRIALS trial_result · 2009-02-12
  Clinical Trial Update: A Safety and Efficacy Study of Alefacept in the Treatment of Moderate to Severe Erosive Mucosal Lichen Planus [Phase 2]

  Phase 2 safety and efficacy study of alefacept for moderate to severe erosive mucosal lichen planus was terminated.

• FDA approval · 2008-03-10
  FDA Approved: CLOBETASOL PROPIONATE — Original Application (Padagis Israel Pharmaceuticals Ltd)

  FDA approved an original application for a generic clobetasol propionate topical product by Padagis Israel Pharmaceuticals Ltd.

• CLINICAL_TRIALS trial_result · 2008-03-04
  Clinical Trial Update: Evaluation and Treatment of Oral Soft Tissue Diseases [NA]

  A National Institute of Dental and Craniofacial Research-sponsored clinical trial evaluating oral soft tissue diseases has completed. The st…